Literature DB >> 32323319

Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Bin He1, Sylvia E Perez1, Sang H Lee2,3, Stephen D Ginsberg4,5,6,7, Michael Malek-Ahmadi8, Elliott J Mufson1.   

Abstract

The precuneus (PreC; Brodmann area 7), a key hub within the default mode network (DMN) displays amyloid and tau-containing neurofibrillary tangle (NFT) pathology during the onset of Alzheimer's disease (AD). PreC layer III projection neurons contain lysosomal hydrolase cathepsin D (CatD), a marker of neurons vulnerable to NFT pathology. Here we applied single population laser capture microdissection coupled with custom-designed microarray profiling to determine the genetic signature of PreC CatD-positive-layer III neurons accrued from postmortem tissue obtained from the Rush Religious Orders Study (RROS) cases with a premortem clinical diagnosis of no cognitive impairment (NCI), mild cognitive impairment (MCI) and AD. Expression profiling revealed significant differential expression of key transcripts in MCI and AD compared to NCI that underlie signaling defects, including dysregulation of genes within the endosomal-lysosomal and autophagy pathways, cytoskeletal elements, AD-related genes, ionotropic and metabotropic glutamate receptors, cholinergic enzymes and receptors, markers of monoamine neurotransmission as well as steroid-related transcripts. Pervasive defects in both MCI and AD were found in select transcripts within these key gene ontology categories, underscoring the vulnerability of these corticocortical projection neurons during the onset and progression of dementia. Select PreC dysregulated genes detected via custom-designed microarray analysis were validated using qPCR. In summary, expression profiling of PreC CatD -positive layer III neurons revealed significant dysregulation of a mosaic of genes in MCI and AD that were not previously appreciated in terms of their indication of systems-wide signaling defects in a key hub of the DMN.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; RRID; expression profiling; laser capture microdissection; microarray; mild cognitive impairment; neurons; precuneus

Year:  2020        PMID: 32323319      PMCID: PMC7492791          DOI: 10.1002/cne.24929

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  105 in total

Review 1.  Molecular thanatopsis: a discourse on the BCL2 family and cell death.

Authors:  E Yang; S J Korsmeyer
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

2.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Authors:  Frederick A Schmitt; Peter T Nelson; Erin Abner; Stephen Scheff; Gregory A Jicha; Charles Smith; Gregory Cooper; Marta Mendiondo; Deborah D Danner; Linda J Van Eldik; Allison Caban-Holt; Mark A Lovell; Richard J Kryscio
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

3.  Alzheimer neuropathologic alterations in aged cognitively normal subjects.

Authors:  D G Davis; F A Schmitt; D R Wekstein; W R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  1999-04       Impact factor: 3.685

4.  Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.

Authors:  José Luis Albasanz; Esther Dalfó; Isidro Ferrer; Mairena Martín
Journal:  Neurobiol Dis       Date:  2005-06-08       Impact factor: 5.996

5.  The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.

Authors:  Matthias Riemenschneider; Kaj Blennow; Stefan Wagenpfeil; Niels Andreasen; Jonathan A Prince; Simon M Laws; Hans Förstl; Alexander Kurz
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

6.  Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.

Authors:  E K Perry; C M Morris; J A Court; A Cheng; A F Fairbairn; I G McKeith; D Irving; A Brown; R H Perry
Journal:  Neuroscience       Date:  1995-01       Impact factor: 3.590

7.  Altered effective connectivity of the default mode network in resting-state amnestic type mild cognitive impairment.

Authors:  Hao Yan; Yumei Zhang; Hongyan Chen; Yonghui Wang; Yijun Liu
Journal:  J Int Neuropsychol Soc       Date:  2013-02-21       Impact factor: 2.892

8.  Relation of neuropathology to cognition in persons without cognitive impairment.

Authors:  David A Bennett; Robert S Wilson; Patricia A Boyle; Aron S Buchman; Julie A Schneider
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

9.  Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation.

Authors:  Jeffrey A Blair; Chunyu Wang; Damarys Hernandez; Sandra L Siedlak; Mark S Rodgers; Rojan K Achar; Lara M Fahmy; Sandy L Torres; Robert B Petersen; Xiongwei Zhu; Gemma Casadesus; Hyoung-Gon Lee
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

Review 10.  Cholinotrophic molecular substrates of mild cognitive impairment in the elderly.

Authors:  Elliott J Mufson; Scott E Counts; Margaret Fahnestock; Stephen D Ginsberg
Journal:  Curr Alzheimer Res       Date:  2007-09       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.